151 related articles for article (PubMed ID: 12969816)
1. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
[No Abstract] [Full Text] [Related]
2. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
[TBL] [Abstract][Full Text] [Related]
3. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
5. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
Townsend A; Drakesmith H
Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
[TBL] [Abstract][Full Text] [Related]
6. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
[TBL] [Abstract][Full Text] [Related]
8. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation.
Mattman A; Huntsman D; Lockitch G; Langlois S; Buskard N; Ralston D; Butterfield Y; Rodrigues P; Jones S; Porto G; Marra M; De Sousa M; Vatcher G
Blood; 2002 Aug; 100(3):1075-7. PubMed ID: 12130528
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HFE and TFR2 gene mutations in patients with acute leukemia.
Veneri D; Franchini M; Krampera M; de Matteis G; Solero P; Pizzolo G
Leuk Res; 2005 Jun; 29(6):661-4. PubMed ID: 15863206
[TBL] [Abstract][Full Text] [Related]
10. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes.
Mendes AI; Ferro A; Martins R; Picanço I; Gomes S; Cerqueira R; Correia M; Nunes AR; Esteves J; Fleming R; Faustino P
Ann Hematol; 2009 Mar; 88(3):229-34. PubMed ID: 18762941
[TBL] [Abstract][Full Text] [Related]
11. Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease?
Chan V; Wong MS; Ooi C; Chen FE; Chim CS; Liang RH; Todd D; Chan TK
Blood Cells Mol Dis; 2003; 30(1):107-11. PubMed ID: 12667993
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R.
Lee PL; Barton JC
Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658
[TBL] [Abstract][Full Text] [Related]
13. HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients.
Saliou P; Le Gac G; Mérour MC; Tripogney C; Chanu B; Gourlaouen I; Nousbaum JB; Férec C; Scotet V
Ann Hematol; 2015 Jul; 94(7):1225-7. PubMed ID: 25740382
[No Abstract] [Full Text] [Related]
14. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
[TBL] [Abstract][Full Text] [Related]
16. Genetic hemochromatosis update.
Brissot P; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Loréal O
Acta Gastroenterol Belg; 2005; 68(1):33-7. PubMed ID: 15832585
[TBL] [Abstract][Full Text] [Related]
17. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
Barton JC; Lee PL; West C; Bottomley SS
Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HFE and TFR2 gene mutation in 118 Ligurian rheumatic patients.
Rovetta G; Monteforte P; Buffrini L; Grignolo MC; Franchin F
Minerva Med; 2004 Dec; 95(6):535-9. PubMed ID: 15785438
[TBL] [Abstract][Full Text] [Related]
19. Iron overload: molecular clues to its cause.
Kühn LC
Trends Biochem Sci; 1999 May; 24(5):164-6. PubMed ID: 10322426
[No Abstract] [Full Text] [Related]
20. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
